Work

The First-in-Human Clinical Trial of iPSC-Derived Platelets (iPLAT1): Autologous Transfusion to an Aplastic Anemia Patient with Alloimmune Platelet Transfusion Refractoriness

Year: 2021

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2021-145814

Authors: Naoshi Sugimoto, Junya Kanda, Sou Nakamura, Toshiyuki Kitano, Masakatsu Hishizawa, Tadakazu Kondo, Shin Shimizu, Akiko Shigemasa, Hideyo Hirai, Harue Tada, Manabu Minami, Naohide Watanabe, Masayuki Nogawa, Makoto Handa, Yoshihiko Tani, Akifumi Takaori-Kondo, Koji Eto

Institutions: Kyoto University, Center for iPS Cell Research and Application, Kyoto University, Kyoto University Hospital, Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Keio University, Osaka Prefectural Red Cross Blood Center, Chiba University

Language: English

Topic: Blood transfusion and management

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3211512740

Cites:

Cited by: 9

Related to: 10